clinicaltrials.gov 5-amino-1mq Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic 5-Amino-1MQ

The emphasis of this page is therefore on catalog clarity, research-only designation, and practical logistics rather than any claim regarding biological application or outcome

To learn more about the benefits, risks, & differences of compounded medication substitutes you may visit the FDA Drug Shortage List & FDA Compounding Substitutions Information Page

These symptoms may appear gradually and should not be ignored, especially when they persist or worsen over time

In the UK, these products are regulated as food supplements under food law, not as licensed medicines, and formulations can vary considerably between brands

after reconstitution, refrigerate at 28 C (35.646.4 F) and use within 24 weeks [4]